Category: Infectious Diseases
Global Infectious Diseases
-
Global Bio-detection Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and ... Read More
-
Global Zika Virus Therapeutics Market 2024-2028
... zika virus therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Zika Virus Competitive Landscape Professional Research Report 2024
... species mosquitoes, particularly Aedes aegypti and Aedes albopictus. The virus gained global attention during outbreaks in various regions, including the Americas, Africa, Asia, and the Pacific Islands. Zika virus infection is typically mild or asymptomatic, ... Read More
-
Global Zika Virus IgM Test kit Competitive Landscape Professional Research Report 2024
... identifying recent or ongoing Zika virus infections, as IgM antibodies are produced by the immune system in response to the virus within a few weeks of infection. The kit typically contains the necessary reagents and ... Read More
-
Infectious Disease Diagnostics Market Forecasts to 2030 – Global Analysis By Product (Assays & Reagents, Kits, Consumables, Instruments and Software & Services), Disease (Bacterial Infections, Viral Infections, Fungal Infections, Parasitic Infections and Other Infectious Diseases), Technology (Immunodiagnostics, Microbiology, Polymerase Chain Reaction, Next-generation Sequencing and Other Technologies), End User and By Geography
... Technology (Immunodiagnostics, Microbiology, Polymerase Chain Reaction, Next-generation Sequencing and Other Technologies), End User and By Geography According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $23.63 billion in 2024 and is ... Read More
-
Cytomegalovirus Treatment Market by Diseases (Encephalitis, Gastrointestinal Ulcers, Pneumonia), Drug (Cidofovir, Foscarnet, Ganciclovir), Distribution Channel, Application - Global Forecast 2024-2030
... to reach USD 576.99 million in 2024, at a CAGR 7.67% to reach USD 903.39 million by 2030. The cytomegalovirus (CMV) treatment includes all aspects of medical practices to manage and treat cytomegalovirus infections, a ... Read More
-
Cell & Gene Therapy Manufacturing Services Market by Type (Cell Therapy, Gene Therapy), Indication (Cardiovascular Diseases, Central Nervous System Disorders, Infectious Diseases), Application, End-User - Global Forecast 2024-2030
... Market size was estimated at USD 17.34 billion in 2023 and expected to reach USD 19.98 billion in 2024, at a CAGR 15.81% to reach USD 48.45 billion by 2030. Cell and gene therapy manufacturing ... Read More
-
Infectious Diseases In-Vitro Diagnostics Market by Product (Instruments, Reagents, Software), Technology (Immunochemistry, Microbiology, Molecular Diagnostics), Indication, End-user - Global Forecast 2024-2030
... 2023 and expected to reach USD 52.51 billion in 2024, at a CAGR 7.22% to reach USD 79.95 billion by 2030. The infectious diseases in-vitro diagnostics market comprises devices, consumables, and services used to detect ... Read More
-
Pneumococcal Vaccine Market by Type (Conjugate Vaccines, Polysaccharide Vaccines), Indication (Bronchitis, Meningitis, Pneumonia), Age Group, Distribution - Global Forecast 2024-2030
... to reach USD 11.56 billion in 2024, at a CAGR 7.92% to reach USD 18.30 billion by 2030. The pneumococcal vaccine is designed to protect against infections caused by the streptococcus pneumoniae bacteria. These infections ... Read More
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
... to reach USD 901 million in 2029 from USD 579 million in 2024, at a CAGR of 9.2% during the forecast period. The growth of this market can be attributed to the increasing prevalence of ... Read More
-
Global Antimicrobial Resistance Market Size Study, By Drug Class (Combination Therapies, Tetracyclines, Cephalosporins), By Indication (Complicated Urinary Tract Infections, Blood Stream Infections, Community Acquired Pneumonia), By Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors), and Regional Forecasts 2022-2032
... Inhibitors), and Regional Forecasts 2022-2032 Global Antimicrobial Resistance Market is valued approximately at USD 4.95 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.6% over the forecast ... Read More
-
Global Hospital Infection Therapeutics Market 2024-2028
... period. Our report on the hospital infection therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Global Antibiotics Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the ... Read More
-
RNA Therapeutics Market Assessment, By Type [RNA Interference Therapeutics, mRNA Therapeutics, Antisense Oligonucleotide Therapeutics, Others], By Product [Vaccines, Drugs], By Indication [Rare Genetic Diseases/Hereditary Diseases, Infectious Diseases, Others], By End-user [Hospitals, Academic Research Centers, Contract Research Organizations, Others], By Region, Opportunities and Forecast, 2017-2031F
... Research Organizations, Others], By Region, Opportunities and Forecast, 2017-2031F Global RNA therapeutics market size was valued at USD 23,067.85 million in 2023, expected to reach USD 54,464.95 million in 2031, with a CAGR of 11.25% ... Read More
-
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious diseases,Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel ,Patient Care Setting, & Region - Global Forecast to 2029
... is projected to reach USD 1139.4 billion by 2029 from USD 754.5 billion in 2024, at a CAGR of 8.6% from 2024 to 2029. The increased prevalence of chronic diseases such as diabetes, cancer, autoimmune ... Read More
-
Global Zika Virus Testing Market Analysis and Forecast 2024-2030
... virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint ... Read More
-
Global Hospital Acquired Infections Therapeutic Databank Market Report
... 2.02% from 2023 to 2031. Antibacterial Drugs segment is expected to be the highest contributor to this market, with $9,937.3 Million in 2022, and is anticipated to reach $11,555.8 Million by 2031, registering a CAGR ... Read More
-
Global Zika Virus Testing Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika ... Read More
-
Hospital Acquired Pneumonia (HAP) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Hospital Acquired Pneumonia (HAP). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Medical Microbiology Testing Technologies Market (Indication: Respiratory Diseases, Neurological Diseases, Infectious Diseases, and Others; and Technology: Cell Culture, Microscopy, and Serology) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Technologies Market – Scope of Report TMR’s report on the global medical microbiology testing technologies market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators ... Read More
-
Point of Care Infectious Disease Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology
... and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is ... Read More
-
Global Immunodiagnostics Market Size Study & Forecast, by Product (Instruments, Reagents & Consumables), By Application (Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases, Others), By End user (Clinical Laboratories, Hospitals, Physician’s Offices, Others), and Regional Analysis, 2023-2030
... and Regional Analysis, 2023-2030 Global Immunodiagnostics Market is valued approximately at USD 17.83 billion in 2022 and is anticipated to grow with a growth rate of more than 7.30% over the forecast period 2023-2030. Immunodiagnostics ... Read More
-
Global Artificial Intelligence (Ai) In Epidemiology Market Forecast 2024-2032
... facilitating the market’s growth include the early detection and surveillance of disease outbreaks, the growing need for predictive modeling to forecast disease trends, and data availability for epidemiological research. MARKET INSIGHTS Early detection and surveillance ... Read More
-
In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Global Forecast to 2029
... diagnostics market is projected to reach USD 119.4 billion by 2029 from USD 85.2 billion in 2024, at a CAGR of 6.9% during the forecast period. With the rapid growth in the geriatric population globally, ... Read More
-
Global Pneumonia Vaccine Market Growth 2024-2030
... Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Pneumonia Vaccine market. Pneumonia Vaccine ... Read More
Research Assistance
